Spine Top Stories Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain byJosh SandbergSeptember 24, 2024
Spine PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology byJosh SandbergSeptember 13, 2024
Spine Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain byTim AllenApril 25, 2024
Spine Relievant Medsystems Introduces Next-Generation Access Instruments to Advance Intracept Procedure for Chronic Vertebrogenic Low Back Pain byJosh SandbergJuly 14, 2023
Spine Relievant Medsystems Announces Pooled Three-Year Outcomes from Intracept Procedure that Demonstrate Long-Term Pain Relief and Reduced Opioid Use in Chronic Vertebrogenic Low Back Pain Patients byJosh SandbergJune 15, 2023
Financial Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain byJosh SandbergApril 20, 2023
Spine SPR Therapeutics’ 14-Month Data from Multicenter Low Back Pain Trial Demonstrates Significant, Durable Impacts on Pain Intensity, Disability, and Pain Interference byJosh SandbergMarch 16, 2023
Spine Dr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon Advisor byJosh SandbergDecember 22, 2022
Neuro Spine Mainstay Medical announces the release of post-marketing data from the ongoing ReActiv8®-C study in patients with chronic low back pain byChris StewartNovember 23, 2022
Neuro Spine Relievant Medsystems Announces Updated Policy Statement and Guideline for Basivertebral Nerve Ablation from the International Society for the Advancement of Spine Surgery byChris StewartNovember 9, 2022
